Last updated on January 2019

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B


Brief description of study

This trial is conducted globally. The aim of the trial is to investigate the safety and efficacy of nonacog beta pegol (N9-GP) in previously untreated patients with Haemophilia B.

Clinical Study Identifier: NCT02141074

Find a site near you

Start Over

Novo Nordisk Investigational Site

Los Angeles, CA United States
  Connect »

Novo Nordisk Investigational Site

New Orleans, LA United States
  Connect »

Novo Nordisk Investigational Site

Philadelphia, PA United States
  Connect »

Novo Nordisk Investigational Site

Salt Lake City, UT United States
  Connect »

Novo Nordisk Investigational Site

Shizuoka-shi, Shizuoka, Japan
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.